Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Preventive Vaccines Market Size Analysis from 2022 to 2027
1.5.1 Global Preventive Vaccines Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Preventive Vaccines Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Preventive Vaccines Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Preventive Vaccines Industry Impact
Chapter 2 Global Preventive Vaccines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Preventive Vaccines (Volume and Value) by Type
2.1.1 Global Preventive Vaccines Consumption and Market Share by Type (2016-2021)
2.1.2 Global Preventive Vaccines Revenue and Market Share by Type (2016-2021)
2.2 Global Preventive Vaccines (Volume and Value) by Application
2.2.1 Global Preventive Vaccines Consumption and Market Share by Application (2016-2021)
2.2.2 Global Preventive Vaccines Revenue and Market Share by Application (2016-2021)
2.3 Global Preventive Vaccines (Volume and Value) by Regions
2.3.1 Global Preventive Vaccines Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Preventive Vaccines Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Preventive Vaccines Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Preventive Vaccines Consumption by Regions (2016-2021)
4.2 North America Preventive Vaccines Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Preventive Vaccines Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Preventive Vaccines Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Preventive Vaccines Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Preventive Vaccines Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Preventive Vaccines Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Preventive Vaccines Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Preventive Vaccines Sales, Consumption, Export, Import (2016-2021)
4.10 South America Preventive Vaccines Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Preventive Vaccines Market Analysis
5.1 North America Preventive Vaccines Consumption and Value Analysis
5.1.1 North America Preventive Vaccines Market Under COVID-19
5.2 North America Preventive Vaccines Consumption Volume by Types
5.3 North America Preventive Vaccines Consumption Structure by Application
5.4 North America Preventive Vaccines Consumption by Top Countries
5.4.1 United States Preventive Vaccines Consumption Volume from 2016 to 2021
5.4.2 Canada Preventive Vaccines Consumption Volume from 2016 to 2021
5.4.3 Mexico Preventive Vaccines Consumption Volume from 2016 to 2021
Chapter 6 East Asia Preventive Vaccines Market Analysis
6.1 East Asia Preventive Vaccines Consumption and Value Analysis
6.1.1 East Asia Preventive Vaccines Market Under COVID-19
6.2 East Asia Preventive Vaccines Consumption Volume by Types
6.3 East Asia Preventive Vaccines Consumption Structure by Application
6.4 East Asia Preventive Vaccines Consumption by Top Countries
6.4.1 China Preventive Vaccines Consumption Volume from 2016 to 2021
6.4.2 Japan Preventive Vaccines Consumption Volume from 2016 to 2021
6.4.3 South Korea Preventive Vaccines Consumption Volume from 2016 to 2021
Chapter 7 Europe Preventive Vaccines Market Analysis
7.1 Europe Preventive Vaccines Consumption and Value Analysis
7.1.1 Europe Preventive Vaccines Market Under COVID-19
7.2 Europe Preventive Vaccines Consumption Volume by Types
7.3 Europe Preventive Vaccines Consumption Structure by Application
7.4 Europe Preventive Vaccines Consumption by Top Countries
7.4.1 Germany Preventive Vaccines Consumption Volume from 2016 to 2021
7.4.2 UK Preventive Vaccines Consumption Volume from 2016 to 2021
7.4.3 France Preventive Vaccines Consumption Volume from 2016 to 2021
7.4.4 Italy Preventive Vaccines Consumption Volume from 2016 to 2021
7.4.5 Russia Preventive Vaccines Consumption Volume from 2016 to 2021
7.4.6 Spain Preventive Vaccines Consumption Volume from 2016 to 2021
7.4.7 Netherlands Preventive Vaccines Consumption Volume from 2016 to 2021
7.4.8 Switzerland Preventive Vaccines Consumption Volume from 2016 to 2021
7.4.9 Poland Preventive Vaccines Consumption Volume from 2016 to 2021
Chapter 8 South Asia Preventive Vaccines Market Analysis
8.1 South Asia Preventive Vaccines Consumption and Value Analysis
8.1.1 South Asia Preventive Vaccines Market Under COVID-19
8.2 South Asia Preventive Vaccines Consumption Volume by Types
8.3 South Asia Preventive Vaccines Consumption Structure by Application
8.4 South Asia Preventive Vaccines Consumption by Top Countries
8.4.1 India Preventive Vaccines Consumption Volume from 2016 to 2021
8.4.2 Pakistan Preventive Vaccines Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Preventive Vaccines Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Preventive Vaccines Market Analysis
9.1 Southeast Asia Preventive Vaccines Consumption and Value Analysis
9.1.1 Southeast Asia Preventive Vaccines Market Under COVID-19
9.2 Southeast Asia Preventive Vaccines Consumption Volume by Types
9.3 Southeast Asia Preventive Vaccines Consumption Structure by Application
9.4 Southeast Asia Preventive Vaccines Consumption by Top Countries
9.4.1 Indonesia Preventive Vaccines Consumption Volume from 2016 to 2021
9.4.2 Thailand Preventive Vaccines Consumption Volume from 2016 to 2021
9.4.3 Singapore Preventive Vaccines Consumption Volume from 2016 to 2021
9.4.4 Malaysia Preventive Vaccines Consumption Volume from 2016 to 2021
9.4.5 Philippines Preventive Vaccines Consumption Volume from 2016 to 2021
9.4.6 Vietnam Preventive Vaccines Consumption Volume from 2016 to 2021
9.4.7 Myanmar Preventive Vaccines Consumption Volume from 2016 to 2021
Chapter 10 Middle East Preventive Vaccines Market Analysis
10.1 Middle East Preventive Vaccines Consumption and Value Analysis
10.1.1 Middle East Preventive Vaccines Market Under COVID-19
10.2 Middle East Preventive Vaccines Consumption Volume by Types
10.3 Middle East Preventive Vaccines Consumption Structure by Application
10.4 Middle East Preventive Vaccines Consumption by Top Countries
10.4.1 Turkey Preventive Vaccines Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Preventive Vaccines Consumption Volume from 2016 to 2021
10.4.3 Iran Preventive Vaccines Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Preventive Vaccines Consumption Volume from 2016 to 2021
10.4.5 Israel Preventive Vaccines Consumption Volume from 2016 to 2021
10.4.6 Iraq Preventive Vaccines Consumption Volume from 2016 to 2021
10.4.7 Qatar Preventive Vaccines Consumption Volume from 2016 to 2021
10.4.8 Kuwait Preventive Vaccines Consumption Volume from 2016 to 2021
10.4.9 Oman Preventive Vaccines Consumption Volume from 2016 to 2021
Chapter 11 Africa Preventive Vaccines Market Analysis
11.1 Africa Preventive Vaccines Consumption and Value Analysis
11.1.1 Africa Preventive Vaccines Market Under COVID-19
11.2 Africa Preventive Vaccines Consumption Volume by Types
11.3 Africa Preventive Vaccines Consumption Structure by Application
11.4 Africa Preventive Vaccines Consumption by Top Countries
11.4.1 Nigeria Preventive Vaccines Consumption Volume from 2016 to 2021
11.4.2 South Africa Preventive Vaccines Consumption Volume from 2016 to 2021
11.4.3 Egypt Preventive Vaccines Consumption Volume from 2016 to 2021
11.4.4 Algeria Preventive Vaccines Consumption Volume from 2016 to 2021
11.4.5 Morocco Preventive Vaccines Consumption Volume from 2016 to 2021
Chapter 12 Oceania Preventive Vaccines Market Analysis
12.1 Oceania Preventive Vaccines Consumption and Value Analysis
12.2 Oceania Preventive Vaccines Consumption Volume by Types
12.3 Oceania Preventive Vaccines Consumption Structure by Application
12.4 Oceania Preventive Vaccines Consumption by Top Countries
12.4.1 Australia Preventive Vaccines Consumption Volume from 2016 to 2021
12.4.2 New Zealand Preventive Vaccines Consumption Volume from 2016 to 2021
Chapter 13 South America Preventive Vaccines Market Analysis
13.1 South America Preventive Vaccines Consumption and Value Analysis
13.1.1 South America Preventive Vaccines Market Under COVID-19
13.2 South America Preventive Vaccines Consumption Volume by Types
13.3 South America Preventive Vaccines Consumption Structure by Application
13.4 South America Preventive Vaccines Consumption Volume by Major Countries
13.4.1 Brazil Preventive Vaccines Consumption Volume from 2016 to 2021
13.4.2 Argentina Preventive Vaccines Consumption Volume from 2016 to 2021
13.4.3 Columbia Preventive Vaccines Consumption Volume from 2016 to 2021
13.4.4 Chile Preventive Vaccines Consumption Volume from 2016 to 2021
13.4.5 Venezuela Preventive Vaccines Consumption Volume from 2016 to 2021
13.4.6 Peru Preventive Vaccines Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Preventive Vaccines Consumption Volume from 2016 to 2021
13.4.8 Ecuador Preventive Vaccines Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Preventive Vaccines Business
14.1 Sanofi
14.1.1 Sanofi Company Profile
14.1.2 Sanofi Preventive Vaccines Product Specification
14.1.3 Sanofi Preventive Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Abbott
14.2.1 Abbott Company Profile
14.2.2 Abbott Preventive Vaccines Product Specification
14.2.3 Abbott Preventive Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 AstraZeneca
14.3.1 AstraZeneca Company Profile
14.3.2 AstraZeneca Preventive Vaccines Product Specification
14.3.3 AstraZeneca Preventive Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 CSL Ltd
14.4.1 CSL Ltd Company Profile
14.4.2 CSL Ltd Preventive Vaccines Product Specification
14.4.3 CSL Ltd Preventive Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Serum Institute of India
14.5.1 Serum Institute of India Company Profile
14.5.2 Serum Institute of India Preventive Vaccines Product Specification
14.5.3 Serum Institute of India Preventive Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 GlaxoSmithKline
14.6.1 GlaxoSmithKline Company Profile
14.6.2 GlaxoSmithKline Preventive Vaccines Product Specification
14.6.3 GlaxoSmithKline Preventive Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Preventive Vaccines Market Forecast (2022-2027)
15.1 Global Preventive Vaccines Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Preventive Vaccines Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Preventive Vaccines Value and Growth Rate Forecast (2022-2027)
15.2 Global Preventive Vaccines Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Preventive Vaccines Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Preventive Vaccines Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Preventive Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Preventive Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Preventive Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Preventive Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Preventive Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Preventive Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Preventive Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Preventive Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Preventive Vaccines Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Preventive Vaccines Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Preventive Vaccines Consumption Forecast by Type (2022-2027)
15.3.2 Global Preventive Vaccines Revenue Forecast by Type (2022-2027)
15.3.3 Global Preventive Vaccines Price Forecast by Type (2022-2027)
15.4 Global Preventive Vaccines Consumption Volume Forecast by Application (2022-2027)
15.5 Preventive Vaccines Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
